FDA Grants Approval for Sugammadex Sodium ANDA214306 by Zenara
The FDA has granted approval for the ANDA214306 application for Sugammadex Sodium submitted by Zenara.
Asset / Drug
Drug and asset intelligence for Zenara with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.